Onyx Pharma (ONXX) Shares Up 17% as Review May Lead to Sale
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
Shares of Onyx Pharma (Nasdaq: ONXX) are now up about 17.5 percent to $44 following a Bloomberg headline which suggests the company may be weighing a possible sale.
After opening under $39 and trading below $40 for most of the session, the stock marked a fresh 52-week high at $46.07 just seconds after the headline hit.
After opening under $39 and trading below $40 for most of the session, the stock marked a fresh 52-week high at $46.07 just seconds after the headline hit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Texas Instruments (TXN) jumps on first above-consensus guide in seven years
- Affirm stock drops on report Walmart-backed fintech One is launching BNPL; Mizuho says 'concerns overblown'
Create E-mail Alert Related Categories
Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
